Arcutis Biotherapeutics debuts IPO
Arcutis Biotherapeutics, a biopharmaceutical company, has raised about $159.4 million for its IPO after pricing its over 9.3 million shares at $17 per share.
Arcutis Biotherapeutics, a biopharmaceutical company, has raised about $159.4 million for its IPO after pricing its over 9.3 million shares at $17 per share.
Copyright PEI Media
Not for publication, email or dissemination